Hongbing Shen
Ningbo University(CN)Jiangsu University(CN)Fujian Medical University(CN)Nanjing University of Chinese Medicine(CN)Shandong University of Traditional Chinese Medicine(CN)Capital University(US)Sun Yat-sen University(CN)China Pharmaceutical University(CN)Hangzhou Normal University(CN)Nanjing Forestry University(CN)Shanghai Jiao Tong University(CN)Capital Medical University(CN)Chinese Center For Disease Control and Prevention(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Soochow University(CN)Nanjing Health and Health Commission(CN)Ningbo No. 2 Hospital(CN)Ministry of Education(KR)Suzhou Municipal Hospital(CN)First Affiliated Hospital of Fujian Medical University(CN)Jiangsu Cancer Hospital(CN)Yancheng Central Blood Station(CN)Sun Yat-sen University Cancer Center(CN)Kai Biotech (South Korea)(KR)Jiangsu Province Hospital(CN)Ningbo University Affiliated Hospital(CN)Ningbo No.6 Hospital(CN)Ningbo First Hospital(CN)Fujian Agriculture and Forestry University(CN)East China Normal University(CN)Southeast University(CN)Nanjing Medical University(CN)Xi'an Jiaotong University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer-related molecular mechanisms research, Genetic Associations and Epidemiology, Epigenetics and DNA Methylation, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China(2020)1,373 cited
- → Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer(2010)799 cited
- → Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes(2017)774 cited
- → Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study(2017)660 cited
- → Genetic variants of miRNA sequences and non–small cell lung cancer survival(2008)585 cited
- → Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma(2010)449 cited